Effect of Albumin on Tumor Cells In Vitro

Bull Exp Biol Med. 2020 Dec;170(2):251-253. doi: 10.1007/s10517-020-05045-8. Epub 2020 Dec 2.

Abstract

The study examined the effect of BSA on cultured cells of breast cancer, erythroleukemia, and ovarian carcinoma. BSA cytotoxic activity was examined with light microscopy and spectrophotometry in the concentration range of 6.25 to 50 mg/ml. The high concentrations of BSA disrupted the tumor cells in parallel with formation of vesicular debris. The destruction parameters were similar in diverse types of cells: BSA (50 mg/ml) disrupted 75.5±0.7% breast cancer cells, 75.8±0.2% erythroleukemia cells, and 78.8±0.1% cells of ovarian carcinoma (p≥0.05). The effect of BSA was dose-dependent in each type of cells. The data attest that BSA can disrupt various tumor cells in vitro.

Keywords: albumin; breast cancer; erythroleukemia; ovarian carcinoma; tumor cells.

MeSH terms

  • Albumins / chemistry*
  • Animals
  • Antineoplastic Agents / pharmacology
  • Breast Neoplasms / drug therapy*
  • Carcinoma / drug therapy*
  • Cattle
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • In Vitro Techniques
  • K562 Cells
  • Leukemia, Erythroblastic, Acute / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Serum Albumin, Bovine / metabolism*
  • Serum Albumin, Human / metabolism
  • Tumor Cells, Cultured

Substances

  • Albumins
  • Antineoplastic Agents
  • Serum Albumin, Bovine
  • Serum Albumin, Human